Kwick Forensic Solutions Ltd. IPO

Kwick Forensic Solutions IPO was a Fresh Issue-cum-Offer for Sale of 56,41,600 equity shares aggregating up to ₹50.77 Cr at the upper price band of ₹90 per share. The issue comprised a fresh issue of 45,61,600 equity shares aggregating to ₹41.05 Cr and an

Closed Book Built Issue BSE SME
Issue size ₹50.77 CrPrice band ₹85 – ₹90Face value ₹10Lot size 1600 sharesLatest GMP ₹85Updated Sep 2, 2026

Kwick Forensic Solutions Ltd. IPO Details

Kwick Forensic Solutions IPO opened for subscription on 27 August 2026 and closed on 31 August 2026. The basis of allotment is scheduled for 1 September 2026, refunds are scheduled to begin on 2 September 2026, shares are scheduled to be credited to Demat accounts on 2 September 2026 and the tentative listing date is 3 September 2026.

IPO Open Date
Aug 27, 2026
IPO Close Date
Aug 31, 2026
Price Band
₹85 – ₹90
Face Value
₹10
Lot Size
1600 Shares
Listing Date
Sep 3, 2026
Total Issue Size
₹50.77 Cr
Fresh Issue
₹41.05 Cr
Offer for Sale
₹9.72 Cr
Issue Type
Book Built Issue
Min Investment
₹144,000
Registrar
Bigshare Services Private Limited

Kwick Forensic Solutions Ltd. IPO GMP

Kwick Forensic Solutions IPO GMP was reported at ₹85 on 31 August 2026 by one grey-market tracking source, against the upper issue price of ₹90, implying an unofficial estimated price of ₹175. GMP figures are unofficial and can differ between market sources; they are not exchange data and should not be treated as a guaranteed listing price.

Latest GMP
₹85
Est. Listing Price
₹175
Est. Listing Gain
94.44%

See full day-wise GMP & listing estimate →

Kwick Forensic Solutions Ltd. IPO Timeline (Tentative)

Kwick Forensic Solutions IPO opened on 27 August 2026 and closed on 31 August 2026. The basis of allotment is scheduled for 1 September 2026, refunds and Demat credit are scheduled for 2 September 2026, and the shares are scheduled to list on BSE SME on 3 September 2026.

EventTentative Date
IPO Open DateThu, Aug 27, 2026
IPO Close DateMon, Aug 31, 2026
Basis of AllotmentTue, Sep 1, 2026
Initiation of RefundsWed, Sep 2, 2026
Credit of Shares to DematWed, Sep 2, 2026
Listing DateThu, Sep 3, 2026
Anchor Investor Bidding25 August 2026
IPO Opens27 August 2026
IPO Closes31 August 2026
Basis of Allotment1 September 2026
Refund Initiation2 September 2026
Credit of Shares to Demat2 September 2026
Listing Date3 September 2026

Kwick Forensic Solutions Ltd. IPO Lot Size

The lot size for Kwick Forensic Solutions IPO was 1,600 shares. At the upper price band of ₹90, the minimum retail application required 2 lots, or 3,200 shares, amounting to ₹2,88,000. HNI applications started from 3 lots, or 4,800 shares.

ApplicationLotsSharesAmount (₹)
Retail (Min)23,2002,88,000
Retail (Max)23,2002,88,000
S-HNI (Min)34,8004,32,000
S-HNI (Max)69,6008,64,000
B-HNI (Min)711,20010,08,000

Kwick Forensic Solutions Ltd. IPO Reservation

The total offer comprised 56,41,600 equity shares. The issue included 26,73,600 shares for QIBs including anchor investors, 8,06,400 shares for NIIs, 18,78,400 shares for Retail Individual Investors and 2,83,200 shares reserved for the Market Maker.

QIB 19% NII 14% Retail 33%

Kwick Forensic Solutions Ltd. IPO Subscription

Kwick Forensic Solutions IPO was subscribed 272.50 times overall based on the final reported subscription figures. The QIB category excluding anchors was subscribed 227.85 times, the NII category 237.01 times and the Retail Individual Investor category 318.52 times.

CategorySubscription (times)
QIB227.85
NII237.01
RII318.52
Total272.50

About Kwick Forensic Solutions Ltd.

Kwick Forensic Solutions Limited is a Chennai-based company engaged in providing forensic science, evidence management, cyber and digital forensics, DNA forensics and law-enforcement solutions across India. The company was incorporated on 4 March 2005 as Kwick Soft Solutions Private Limited and subsequently expanded its business into forensic technologies and solutions.

The company initially focused on software development, including 3D rendering, animation and simulation for construction-sector applications. It later expanded into forensic training technologies and, from FY2015, began providing end-to-end products, solutions, tools and technologies for forensic sciences, fingerprint science, cyber and digital forensics, social-media analytics, big-data analytics and Total Evidence Management.

Kwick Forensic Solutions operates across several specialised areas of forensic technology. Its product and solution portfolio includes fingerprint and physical evidence kits, evidence collection kits, handheld forensic devices, digital forensic tools, DNA forensic solutions and mobile Crime Scene Investigation vehicles.

The company also provides services connected with its products and solutions, including installation, training, product demonstrations and technical support. Its focus is primarily on law-enforcement and forensic investigation applications.

Its customers include police departments, central and state forensic laboratories, fingerprint bureaus, crime investigation departments, police training academies, universities and other government and private-sector institutions. This gives the company exposure to government and institutional demand for forensic technology and evidence-management solutions.

Kwick Forensic Solutions sources products from both international and domestic original equipment manufacturers. The company has progressively increased domestic procurement with the objective of supporting supply continuity and cost efficiency.

The company also has R&D and quality-management capabilities. Its branch facility is used for research and development, product demonstrations and proof-of-concept forensic laboratory activities.

The company's quality systems are supported by ISO 9001:2015, ISO 14001:2015, ISO/IEC 20000-1:2018 and ISO/IEC 27001:2022 certifications. It also has registrations with MSME, DSIR and NSIC.

The company's business is divided across multiple forensic technology segments. Its FY2026 revenue mix included forensic science and physical evidence solutions, cyber and digital forensics, DNA forensics, mobile Crime Scene Investigation vehicles and rental and AMC services.

Kwick Forensic Solutions has developed relationships with global forensic technology providers and OEMs. These relationships support its ability to offer specialised products and solutions in the forensic science and law-enforcement market.

As of 31 July 2026, the company had 33 employees on payroll and 12 employees on contract. Employees were deployed across administration, finance, legal and compliance, operations, R&D, sales and marketing, tendering and management functions.

The company reported strong growth in its financial performance during FY2026. Total income increased from ₹65.08 Cr in FY2025 to ₹105.80 Cr in FY2026, while PAT increased from ₹8.56 Cr to ₹13.51 Cr.

For FY2024, FY2025 and FY2026, the company reported total income of ₹30.26 Cr, ₹65.08 Cr and ₹105.80 Cr respectively. PAT for the same periods was ₹2.83 Cr, ₹8.56 Cr and ₹13.51 Cr. 

EBITDA increased from ₹5.45 Cr in FY2024 to ₹12.25 Cr in FY2025 and ₹19.06 Cr in FY2026. Net worth increased from ₹9.86 Cr in FY2024 to ₹27.90 Cr in FY2025 and ₹41.41 Cr in FY2026.

Total assets increased from ₹19.19 Cr in FY2024 to ₹46.79 Cr in FY2025 and ₹60.53 Cr in FY2026. Total borrowings stood at ₹3.24 Cr in FY2024, ₹3.26 Cr in FY2025 and were reported at nil for FY2026 in the available restated financial data.

The company proposed to use ₹31.42 Cr of the fresh issue proceeds towards funding its working-capital requirements. The balance is intended for general corporate purposes.

The working-capital requirement is important because the company deals in specialised forensic equipment and products, where procurement and inventory cycles can require significant funding. The IPO is therefore intended to strengthen the company's operating liquidity and support business growth. 

Kwick Forensic Solutions had also raised ₹14.43 Cr from anchor investors before the public issue opened. The anchor allocation was made on 25 August 2026.

The company operates in a specialised niche where forensic science, digital investigation and evidence-management requirements can support demand for technology and equipment. However, the business also depends on institutional and government customers, tender processes, OEM relationships and continued investment in forensic technologies.

Strengths

  • Provides end-to-end forensic science and evidence-management solutions.
  • Operates across physical evidence, fingerprint, cyber and digital forensics, DNA forensics and related areas.
  • Offers forensic products, equipment, mobile CSI vehicles and digital investigation solutions.
  • Serves police departments, forensic laboratories, crime investigation departments, police academies and other institutions.
  • Has more than two decades of operating experience since incorporation in 2005.
  • Has developed relationships with international and domestic OEMs.
  • Has R&D and proof-of-concept forensic laboratory capabilities.
  • Holds ISO 9001:2015 certification.
  • Holds ISO 14001:2015 certification.
  • Holds ISO/IEC 20000-1:2018 certification.
  • Holds ISO/IEC 27001:2022 certification.
  • Reported strong growth in total income from ₹30.26 Cr in FY2024 to ₹105.80 Cr in FY2026.
  • PAT increased from ₹2.83 Cr in FY2024 to ₹13.51 Cr in FY2026.
  • EBITDA increased from ₹5.45 Cr in FY2024 to ₹19.06 Cr in FY2026.
  • Net worth increased from ₹9.86 Cr in FY2024 to ₹41.41 Cr in FY2026.
  • FY2026 debt-equity was reported at nil in the available restated financial data.
  • The IPO provides ₹31.42 Cr for working-capital requirements.
  • Has increased domestic sourcing to support supply continuity and cost efficiency.
  • Has a diversified portfolio of forensic technologies and services.

Risks to Consider

  • The company operates in a specialised and technology-dependent industry.
  • A substantial portion of its business is connected with government and institutional customers.
  • Government procurement and tender processes can involve long sales cycles and delays.
  • Changes in government spending or procurement policies could affect demand.
  • The company depends on international and domestic OEM suppliers for certain products.
  • Disruptions in OEM relationships or product availability could affect operations.
  • Changes in technology could make existing forensic products or solutions less competitive.
  • The company must continuously invest in research, development and new forensic technologies.
  • The forensic technology market is subject to competition from other domestic and international solution providers.
  • Dependence on specialised technical personnel may create employee-retention risks.
  • The company had 33 employees on payroll and 12 employees on contract as of 31 July 2026, making skilled employee availability important for operations.
  • Working-capital requirements are significant, with ₹31.42 Cr of the IPO proceeds earmarked for working capital.
  • Inventory and procurement cycles may affect cash flows.
  • The company may remain dependent on selected customers, government bodies and institutional contracts.
  • Delays in customer payments could increase working-capital requirements.
  • Foreign-sourced products may expose the company to currency and supply-chain risks.
  • The company operates in a niche market where changes in law-enforcement technology and forensic practices may affect product demand.
  • As an SME-listed company, the shares may have lower liquidity compared with mainboard-listed companies.
  • GMP is unofficial grey-market information and should not be treated as a guaranteed indicator of listing performance.

Kwick Forensic Solutions Ltd. Financials (₹ Cr)

Kwick Forensic Solutions reported total income of ₹30.26 Cr in FY2024, ₹65.08 Cr in FY2025 and ₹105.80 Cr in FY2026. PAT increased from ₹2.83 Cr in FY2024 to ₹8.56 Cr in FY2025 and ₹13.51 Cr in FY2026.

PeriodRevenuePATTotal AssetsNet Worth
FY202430.262.8319.199.86
FY202565.088.5646.7927.90
FY2026105.8013.5160.5341.41

KPIs & Valuation

For FY2026, Kwick Forensic Solutions reported ROE of 38.98%, ROCE of 44.88%, RoNW of 32.62%, EBITDA margin of 18.03%, PAT margin of 12.78% and NAV of ₹24.54 per share.

Pre-IPO EPS
₹8.00
Post-IPO EPS
₹6.30
Pre-IPO P/E
11.25x
Post-IPO P/E
14.29x
NAV
₹24.54
RoNW
32.62%
ROE
38.98%
ROCE
44.88%
Debt/Equity
0.00x
EBITDA Margin
18.03%
PAT Margin
12.78%
Pre-IPO EPS
₹8.00
Post-IPO EPS
₹6.30
Pre-IPO P/E
11.25x
Post-IPO P/E
14.29x

Objects of the Issue

Kwick Forensic Solutions proposed to utilise the net IPO proceeds primarily for funding its working-capital requirements. ₹31.42 Cr was earmarked for working capital, while the remaining proceeds are intended for general corporate purposes.

  • The IPO proceeds were proposed to be utilised for:
  • Funding working-capital requirements – ₹31.42 Cr.
  • General corporate purposes.
  • Issue-related expenses.
  • The IPO comprised both a Fresh Issue and an Offer for Sale. The fresh issue comprised 45,61,600 equity shares aggregating to ₹41.05 Cr at the upper price band, while the Offer for Sale comprised up to 10,80,000 equity shares aggregating to ₹9.72 Cr.

Promoters, Lead Managers & Registrar

Kwick Forensic Solutions Limited is promoted by Shammer Saralal Shah, Sejal Shammer Shah and Tulsidas Hinduja Ashok Kumar. Corporate CapitalVentures Private Limited acted as the Book Running Lead Manager and Bigshare Services Private Limited acted as the Registrar to the Issue. (investkraft.com

Promoters

Shammer Saralal ShahSejal Shammer ShahTulsidas Hinduja Ashok Kumar

Lead Managers (BRLM)

Corporate CapitalVentures Private Limited

Registrar

NameBigshare Services Private Limited
Phone+91 22 6263 8200
Emailipo@bigshareonline.com
Websitehttps://www.bigshareonline.com/

Kwick Forensic Solutions Ltd. IPO Review

Kwick Forensic Solutions operates in a specialised forensic technology market covering physical evidence, fingerprint science, cyber and digital forensics, DNA forensics and evidence management. The company also provides mobile crime-scene investigation vehicles, forensic equipment and related services.

The company's key differentiator is its broad portfolio of forensic products and solutions. It provides products and technologies across multiple forensic applications instead of depending on a single product category.

The company has a long operating history, having been incorporated in 2005. Its transition from software development to forensic science and law-enforcement solutions has allowed it to build a specialised business serving police departments, forensic laboratories and other institutional customers.

The financial performance has been strong in recent years. Total income increased from ₹30.26 Cr in FY2024 to ₹65.08 Cr in FY2025 and ₹105.80 Cr in FY2026. PAT increased from ₹2.83 Cr to ₹8.56 Cr and then ₹13.51 Cr over the same period.

EBITDA increased from ₹5.45 Cr in FY2024 to ₹12.25 Cr in FY2025 and ₹19.06 Cr in FY2026. Net worth also increased significantly from ₹9.86 Cr in FY2024 to ₹41.41 Cr in FY2026.

The company also reported no borrowings for FY2026 in the available restated financial information, compared with ₹3.26 Cr in FY2025. This indicates a stronger reported balance-sheet position entering the IPO.

The IPO's main fresh-issue objective is working capital. The company has earmarked ₹31.42 Cr, making working-capital funding the principal use of the fresh proceeds. This is relevant because the business involves specialised products and equipment that can require inventory and procurement funding.

The company has also developed R&D and quality-management capabilities and holds several ISO certifications. These capabilities can support its ability to serve specialised forensic and law-enforcement requirements.

At the upper issue price of ₹90, the reported pre-IPO EPS was ₹8.00 and the pre-IPO P/E was 11.25x. Based on the post-issue share capital, post-IPO EPS was ₹6.30 and post-IPO P/E was 14.29x.

There is no listed industry peer with a directly comparable business profile, according to the available IPO information. Therefore, a direct peer valuation comparison is not available. (kotakneo.com

The IPO received exceptionally strong demand. The final reported overall subscription was 272.50 times, with QIBs excluding anchors subscribed 227.85 times, NIIs 237.01 times and Retail Individual Investors 318.52 times.

The strong subscription indicates substantial investor demand for the issue, but subscription levels and GMP should not be treated as substitutes for fundamental analysis.

The company has a niche business with diversified forensic offerings, improving financial performance and a strong reported balance sheet. At the same time, investors should consider its dependence on institutional customers, tender-based business, OEM suppliers, specialised employees and working-capital requirements.

Overall, Kwick Forensic Solutions offers exposure to a specialised forensic technology and law-enforcement solutions business. Its strong revenue and profit growth, diversified product portfolio, R&D capabilities and improving financial position are positive factors. However, the company's dependence on government and institutional demand, supplier relationships, specialised technology and working capital remain important risks to evaluate before investing.

Listing Performance

Kwick Forensic Solutions IPO had not yet listed as of 1 September 2026. The tentative listing date is 3 September 2026 on the BSE SME platform. Therefore, actual listing price and listing gain/loss are not available yet.

Particular Price
IPO Issue Price ₹90.00
Listing Price To be announced
Listing Gain/Loss To be announced
Listing Gain/Loss (%) To be announced

 

How to Apply

Kwick Forensic Solutions IPO applications could be made through the ASBA facility and eligible online IPO application mechanisms. The lot size was 1,600 shares, while the minimum retail application was 2 lots, or 3,200 shares, at the upper price band of ₹90.

Through UPI

  1. Log in to your stockbroker app or website.
  2. Go to the IPO section.
  3. Select Kwick Forensic Solutions IPO.
  4. Enter the required number of lots.
  5. Enter your valid UPI ID.
  6. Submit the IPO application.
  7. Approve the UPI mandate received in your UPI application.
  8. Confirm the mandate using your UPI PIN.
  9. The application amount remains blocked in your bank account until the allotment process.
  10. If shares are allotted, the applicable amount is debited; otherwise, the blocked amount is released as per the IPO process.

Prospectus & Documents

The Kwick Forensic Solutions IPO offer document contains the details of the company's business, financial performance, issue structure, objects of the issue, risk factors and other disclosures applicable to the public offer.

Last updated Sep 2, 2026.

Frequently Asked Questions

Kwick Forensic Solutions IPO had a price band of ₹85 to ₹90 per equity share.

The lot size was 1,600 shares. The minimum retail application was 2 lots, or 3,200 shares, requiring ₹2,88,000 at the upper price band of ₹90.

The final reported overall subscription was 272.50 times. QIBs excluding anchors were subscribed 227.85 times, NIIs 237.01 times and Retail Individual Investors 318.52 times.

The basis of allotment is scheduled for 1 September 2026. Refund initiation and Demat credit are scheduled for 2 September 2026.

Kwick Forensic Solutions Limited provides forensic science, evidence-management, cyber and digital forensics, DNA forensics and law-enforcement solutions. Its portfolio includes forensic kits, digital forensic tools, DNA solutions, handheld devices and mobile Crime Scene Investigation vehicles.